ASCO 2015 Highlights

National Harbor, MD—Multiple benefitswere observed for contralateral prophylactic mastectomy (CPM), including cost-effectiveness, in studies presented at the 2010 ASCO Breast Cancer Symposium by investigators from the Mayo Clinic, Rochester, MN.

Read Article

Significant Impact for New Prostate Cancer Therapy

By Charles Bankhead

ESMO 2010 Conference, ESMO

November/December 2010, Vol 1, No 6

Milan—Men with castration-resistant prostate cancer (CRPC) gained 4 months in overall survival (OS) when treated with the novel antiandrogen abiraterone acetate, data from a large randomized trial showed.

Read Article

Value Propositions

Value Propositions, Value Peer-spectives

October 2010, Vol 1, No 5

Read Article

Resource Allocation for Colorectal Cancer Screening

By Naimish Pandya, MD

VBCC Perspectives

October 2010, Vol 1, No 5

Read Article

As Economy Worsens, Financial Factors May Hinder CRC Screening

Colon Cancer, Economics & Value

October 2010, Vol 1, No 5

Read Article

CRC Screening Economics: Diminishing Returns as Technology Advances?

Colon Cancer

October 2010, Vol 1, No 5

Read Article

CMS-FDA Proposed Premarket Parallel Review—The Devil is in the Details

By Jayson Slotnik, JD, MPH

October 2010, Vol 1, No 5

Read Article

Improving Health Economics Research

Economics & Value

October 2010, Vol 1, No 5

It is true that some branches of academic economics sometimes value theoretical insights and technical details over pragmatic results that can be broadly applied. However, most of the core insights of economic analysis tend to be accessible and have highly pragmatic implications.

Read Article

Real-World Decision Makers Decry Information Provided

October 2010, Vol 1, No 5

Read Article

Accelerated Approval: Good Intentions, Difficult Implementation

FDA Approvals, News & Updates

October 2010, Vol 1, No 5

Read Article